{
    "symbol": "GMED",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-08 21:07:04",
    "content": " We achieved the strong third quarter with growth throughout our business delivering sales of $254 million, a 11% as reported or 13% in constant currency growth, with non-GAAP EPS of $0.50, including significant non-operational headwinds for currency and tax rate that Keith will discuss later in the call. I\u00e2\u0080\u0099m pleased with the Q3 results throughout the business with high single-digit growth in US Spine, strong performance from Enabling Tech, record international and trauma sales and meaningful progress in bringing the ecosystem and procedural solutions closer to reality. To help further put that into context, our US Spine business has grown 26.1% over the trailing four quarters when compared to the full year 2019. International revenue for the third quarter was $37.1 million, growing 17.7% as reported or 31.8% on a constant currency basis."
}